NASDAQ: AVEO       Aveo Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
6.70   +0.08 (1.21%)  6.52 - 6.80  147,498


Avg Volume (4 weeks):260,700
4 Weeks Range:6.13 - 6.80
4 Weeks Price Volatility (%):
52 Weeks Range:4.95 - 18.24
52 Weeks Price Volatility (%):
Average Price Target: 8.00
Price Target Upside/Downside: +1.30


No recent Headlines for this stock.

Business Background

AVEO Pharmaceuticals Inc operates as a biopharmaceutical company, which is engaged in the advancement of therapeutics for oncology and other areas of unmet medical need. The company views its operations and manages its business in the US. The firm offers products such as Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. Tivozanib is designed to optimize vascular endothelial growth factor blockade while minimizing off-target toxicities, Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity, AV-380, a humanized inhibitory monoclonal antibody for the treatment or prevention of cachexia; and the AV-353 platform for the potential treatment of pulmonary arterial hypertension.

  felgueiras likes this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1738  3127  245  6382 

Top 10 Active Counters
 BIMI 2.32+1.64 
 TLGT 0.174-0.028 
 BKKT 24.41-6.19 
 RPAI 13.15-0.43 
 AMD 123.15+0.79 
 AAPL 149.46+0.82 
 TSLA 1,020.36-4.50 
 BRPM 11.47+0.28 
 NIO 40.73-0.54 
 FB 312.005-16.685